218 related articles for article (PubMed ID: 15563069)
1. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits].
Wang WG; Yun LH; Wang R; Fu GY; Liu ZY
Yao Xue Xue Bao; 2007 Nov; 42(11):1206-14. PubMed ID: 18300480
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Yang KH; Shin SC
Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
[TBL] [Abstract][Full Text] [Related]
4. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
5. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
6. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.
Ahmed OA; Afouna MI; El-Say KM; Abdel-Naim AB; Khedr A; Banjar ZM
Expert Opin Drug Deliv; 2014 Jul; 11(7):1005-13. PubMed ID: 24702435
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
[TBL] [Abstract][Full Text] [Related]
8. Sex difference in pharmacokinetics of the novel sulfonylurea antidiabetic glimepiride in rats.
Yamazaki H; Tabata S
Arzneimittelforschung; 1993 Dec; 43(12):1317-21. PubMed ID: 8141820
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats.
Du B; Shen G; Wang D; Pang L; Chen Z; Liu Z
Drug Deliv; 2013; 20(1):25-33. PubMed ID: 23311650
[TBL] [Abstract][Full Text] [Related]
10. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
Gao Y; Liang J; Liu J; Xiao Y
Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
[TBL] [Abstract][Full Text] [Related]
11. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
12. A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pre-clinical pharmacokinetic study.
Chakradhar L; Kallem R; Karthik A; Sundari BT; Ramesh S; Mullangi R; Srinivas NR
Biomed Chromatogr; 2008 Jan; 22(1):58-63. PubMed ID: 17642067
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modeling of glimepiride plasma concentration in healthy subjects.
Antonesi IM; Potur R; Potur DM; Ghiciuc CM; Lupuşoru CE
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):949-53. PubMed ID: 22046814
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
Babu RJ; Dhanasekaran M; Vaithiyalingam SR; Singh PN; Pandit JK
Life Sci; 2008 Jan; 82(5-6):273-8. PubMed ID: 18096189
[TBL] [Abstract][Full Text] [Related]
15. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
[TBL] [Abstract][Full Text] [Related]
16. Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation.
Karim A; Zhao Z; Slater M; Bradford D; Schuster J; Laurent A
J Clin Pharmacol; 2007 Jul; 47(7):806-16. PubMed ID: 17463215
[TBL] [Abstract][Full Text] [Related]
17. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
18. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
Mittal A; Sara US; Ali A; Mohammed A
Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
[TBL] [Abstract][Full Text] [Related]
19. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
20. Novel transdermal delivery of Timolol maleate using sugar esters: preclinical and clinical studies.
El-Laithy HM
Eur J Pharm Biopharm; 2009 May; 72(1):239-45. PubMed ID: 19126429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
